Kiltearn Partners LLP Sells 20,600 Shares of Genpact Limited (NYSE:G)

Kiltearn Partners LLP reduced its stake in shares of Genpact Limited (NYSE:G - Free Report) by 10.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 174,650 shares of the business services provider's stock after selling 20,600 shares during the quarter. Genpact comprises approximately 1.2% of Kiltearn Partners LLP's holdings, making the stock its 29th largest position. Kiltearn Partners LLP owned 0.10% of Genpact worth $7,501,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Stifel Financial Corp bought a new stake in shares of Genpact during the third quarter valued at approximately $1,197,000. Blue Trust Inc. raised its stake in Genpact by 8.7% during the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock valued at $217,000 after acquiring an additional 441 shares in the last quarter. Burney Co. boosted its position in Genpact by 242.8% during the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider's stock worth $5,618,000 after acquiring an additional 92,641 shares during the period. KBC Group NV bought a new position in shares of Genpact in the fourth quarter worth $298,000. Finally, JPMorgan Chase & Co. increased its holdings in shares of Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock valued at $122,701,000 after purchasing an additional 2,060,595 shares during the period. 96.03% of the stock is owned by institutional investors and hedge funds.

Genpact Price Performance

NYSE:G traded up $0.09 during trading hours on Tuesday, reaching $50.47. 217,303 shares of the company's stock were exchanged, compared to its average volume of 1,484,699. The company has a market capitalization of $8.87 billion, a P/E ratio of 17.77, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The business's 50-day simple moving average is $50.95 and its two-hundred day simple moving average is $45.19. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Sell-side analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were paid a dividend of $0.17 per share. The ex-dividend date was Tuesday, March 11th. This is a positive change from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.35%. Genpact's dividend payout ratio is currently 23.94%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on G shares. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Mizuho increased their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC raised their price objective on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Finally, TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and upped their target price for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Six investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $48.44.

Insiders Place Their Bets

In other news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company's stock.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.